Leap Therapeutics
Ping Zheng is an experienced professional in statistical programming and biostatistics, currently serving as the Director of Statistical Programming at Leap Therapeutics since June 2023. Previous roles include TEMP-Statistical Programmer to Regeneron at Magnit, Director of Statistical Programming at Checkmate Pharmaceuticals/Regeneron, and Associate Director at Sarepta Therapeutics, Inc. Between May 2015 and June 2018, Ping was a Sr. Statistical Programmer II at Shire and worked at Sunovion Pharmaceuticals Inc. from August 2000 to May 2015 in various statistical programming roles. Earlier experience includes positions as a Biostatistician at Harvard Clinical Research Institute and as a Programmer Analyst at Abt Associate Clinical Trials. Ping Zheng began a career in data analysis in January 1994 at Primedica/Genzyme Transgenics/TSI Mason. The educational background includes a BS in Statistics from the University of Georgia, completed in 1993.
This person is not in any teams
This person is not in any offices
Leap Therapeutics
1 followers
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.